Thermo Fisher partners with OpenAI to accelerate drug development, enhance clinical trials, and optimize biopharma operations with AI technology.
Thermo Fisher Scientific Inc. (NYSE:TMO) stock is trading higher on Thursday. The company announced plans to use artificial intelligence (AI) with OpenAI.
TMO is showing upward movement. See what is driving the move here.
The collaboration will help … [1936 chars]
Source: Benzinga | Published: 2025-10-16T16:15:20Z
Credit: Benzinga
